Kalbe Farma Overview
- Year Founded
-
1966
- Status
-
Public
- Employees
-
12,806
- Stock Symbol
-
KLBF
- Investments
-
11
- Share Price
-
$0.04
- (As of Monday Closing)
Kalbe Farma General Information
Description
PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's revenue is derived from the distribution and logistics segments. Its Product and Services are Prescription /Ethicals, Consumer Health, Nutritionals, Distribution & Logistics, Health Services, Medical Devices, and Others.
Contact Information
Website
www.kalbe.co.idCorporate Office
- Gedung Kalbe
- Jl. Let. Jend. Suprapto Kav. 4
- Jakarta, 10510
- Indonesia
Corporate Office
- Gedung Kalbe
- Jl. Let. Jend. Suprapto Kav. 4
- Jakarta, 10510
- Indonesia
Kalbe Farma Stock Performance
As of 16-Nov-2026, Kalbe Farma’s stock price is $0.04. Its current market cap is $1.92B with 45.2B shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.04 | $0.04 | $0.03 - $0.08 | $1.92B | 45.2B | 61.8M |
Kalbe Farma Financials Summary
As of 30-Sep-2026, Kalbe Farma has a trailing 12-month revenue of $2.22B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,683,237 | 3,142,964 | 3,762,108 | 4,757,496 |
| Revenue | 2,221,037 | 2,140,703 | 2,054,049 | 1,995,910 |
| EBITDA | 300,392 | 328,335 | 304,686 | 283,989 |
| Net Income | 218,598 | 222,103 | 204,011 | 181,358 |
| Total Assets | 1,854,912 | 1,834,654 | 1,799,334 | 1,732,794 |
| Total Debt | 16,345 | 17,766 | 34,191 | 39,612 |
Kalbe Farma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kalbe Farma Comparisons
Industry
Financing
Details
Kalbe Farma Competitors (1)
One of Kalbe Farma’s competitors is Kimia Farma (Persero), a Corporate Backed or Acquired company based in Jakarta, Indonesia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kimia Farma (Persero) | Corporate Backed or Acquired | Jakarta, Indonesia |
Kalbe Farma Signals
Kalbe Farma Investments & Acquisitions (11)
Kalbe Farma’s most recent deal was a Corporate with PROGEN Biotechnik for . The deal was made on 02-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PROGEN Biotechnik | 02-Jan-2023 | Corporate | Biotechnology | ||
| Global Starway Synergy | 06-Dec-2022 | Joint Venture | Logistics | ||
| Sanofi Indonesia | 01-Dec-2022 | Merger/Acquisition | Pharmaceuticals | ||
| SL Pogen | 01-Jan-2021 | Later Stage VC | Drug Discovery | ||
| Kalgen Innolab | 18-Jan-2018 | Joint Venture | Laboratory Services (Healthcare) |
Kalbe Farma ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Kalbe Farma Exits (1)
Kalbe Farma’s most recent exit was on 01-Jan-2021 from SL Pogen. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| SL Pogen | 01-Jan-2021 | Completed |
|
Kalbe Farma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Kalbe Consumer Health | Jakarta, Indonesia | 1956 |
Kalbe Farma FAQs
-
When was Kalbe Farma founded?
Kalbe Farma was founded in 1966.
-
Where is Kalbe Farma headquartered?
Kalbe Farma is headquartered in Jakarta, Indonesia.
-
What is the size of Kalbe Farma?
Kalbe Farma has 12,806 total employees.
-
What industry is Kalbe Farma in?
Kalbe Farma’s primary industry is Drug Discovery.
-
Is Kalbe Farma a private or public company?
Kalbe Farma is a Public company.
-
What is Kalbe Farma’s stock symbol?
The ticker symbol for Kalbe Farma is KLBF.
-
What is the current stock price of Kalbe Farma?
As of 16-Nov-2026 the stock price of Kalbe Farma is $0.04.
-
What is the current market cap of Kalbe Farma?
The current market capitalization of Kalbe Farma is $1.92B.
-
What is Kalbe Farma’s current revenue?
The trailing twelve month revenue for Kalbe Farma is $2.22B.
-
Who are Kalbe Farma’s competitors?
Kimia Farma (Persero) is a competitor of Kalbe Farma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process